MTATP6P15

Across TCGA pan-cancer cohorts, MTATP6P15 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MTATP6P15’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where MTATP6P15 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MTATP6P15 is over-expressed in tumor, although a few such as UCEC show the opposite, repressed pattern.

HNSC, BRCA, and UCEC are the cancer types where MTATP6P15 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTATP6P15 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	+0.016	.008	5	view →
BRCA	Female	All	+0.098	.049	2	view →
UCEC	All	All	−0.064	.038	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

MTATP6P15–HNSC

Open the HNSC breakdown →